SCHEMBL3986546

SCHEMBL3986546

CN1CCN(c2nn(Cc3ccc(F)cc3)c(=O)c3c(O)c4n(c23)CCN(C)C4=O)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.37
ALDH1A1 P00352 6/20 0.36
CYP3A4 P08684 5/20 0.36
HSD17B10 Q99714 4/20 0.36
GLA P06280 2/20 0.36
HRH4 Q9H3N8 1/20 0.36
TSHR P16473 4/20 0.35
CYP1A2 P05177 3/20 0.35
PKM P14618 1/20 0.35
PKLR P30613 1/20 0.35
USP2 O75604 4/20 0.34
CASP1 P29466 3/20 0.34
CASP7 P55210 3/20 0.34
HIF1A Q16665 3/20 0.34
TP53 P04637 2/20 0.34
MAPK1 P28482 2/20 0.34
CYP2C19 P33261 1/20 0.34
CSNK1A1 P48729 1/20 0.34
TMEM97 Q5BJF2 1/20 0.33
SIGMAR1 Q99720 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3985199 0.91 TP53 (0.37) SMN1; SMN2ALDH1A1PKMPKLRTP53
SCHEMBL3985474 0.91 PKM (0.34) SMN1; SMN2ALDH1A1PKMPKLRTP53
SCHEMBL3984969 0.86 PKM (0.38) ALDH1A1PKMPKLRTP53TMEM97
SCHEMBL3983532 0.85 PKM (0.44) ALDH1A1TSHRPKMPKLRTP53
SCHEMBL3982410 0.85 PKM (0.34) SMN1; SMN2ALDH1A1PKMPKLRTP53
SCHEMBL3983836 0.85 PKM (0.39) ALDH1A1PKMPKLRTP53TMEM97
SCHEMBL3985497 0.84 PKM (0.37) PKMPKLRTP53TMEM97SIGMAR1
SCHEMBL1383893 0.84 PKM (0.37) PKMPKLRTP53TMEM97SIGMAR1
SCHEMBL3985794 0.84 PKM (0.37) PKMPKLRTP53TMEM97SIGMAR1
SCHEMBL3981562 0.83 MAPT (0.37) PKMPKLRTP53TMEM97SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538112-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-05-26 US claimed
US-20080287394-A1 Hiv Integrase Inhibitors MERCK & CO., INC. (US) 2008-11-20 US claimed
EP-1756114-B1 HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME (US) 2014-11-19 EP disclosed
US-7538112-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287394-A1 Hiv Integrase Inhibitors DHPS, DPYD, TYMP SMN1; SMN2 4264/4885ALDH1A1 913/4885CYP3A4 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.